Cryptocurrency Market Update: October 2025 Rally Ends with Tariff-Driven Selloff

‘I Don’t Know Who He Is’: Trump’s Binance Pardon Explodes Into Washington Firestorm — What It Means for Crypto, COIN, and BNB Prices

Key facts (updated Nov. 5, 2025)

  • President Donald Trump issued a full and unconditional pardon to Binance founder Changpeng “CZ” Zhao on Oct. 23; the White House framed Biden‑era prosecutions as a “war on cryptocurrency.” [1]
  • In a Nov. 3 “60 Minutes” segment, Trump defended the decision while claiming, “I don’t know who he is,” when pressed about pardoning Zhao. [2]
  • Reporting and congressional statements have zeroed in on potential conflicts after World Liberty Financial (WLF) — a Trump family crypto venture — was boosted by a $2 billion transaction that used its USD1 stablecoin in a Binance deal earlier this year. The White House denies any conflicts. [3]
  • Market snapshot (11:09 UTC, Nov. 5): Bitcoin ~$101,650; Ether ~$3,288; BNB ~$940; Coinbase (COIN) ~$307; MicroStrategy (MSTR) ~$247; Trump Media (DJT) ~$13.82. (Intraday moves negative across the board.)
  • BNB spiked immediately after the pardon (Oct. 24) on heavy volume; analysts framed it as a potential U.S. re‑entry signal for Binance. [4]
  • Lawmakers led by Sen. Elizabeth Warren blasted the move as undermining years of AML enforcement; her banking committee statement urged DOJ/Treasury scrutiny. [5]
  • What’s next: Binance is weighing U.S. options post‑pardon; legal guardrails on the pardon power remain broad but limited to federal crimes and do not erase corporate liabilities. [6]

What happened — and what the president said

On Oct. 23, the White House announced a pardon for Binance founder Changpeng “CZ” Zhao, who pleaded guilty in 2023 to failing to maintain an effective anti‑money‑laundering program and served four months in prison. Press Secretary Karoline Leavitt called it part of ending the prior administration’s “war on cryptocurrency.” Zhao, for his part, said he was “deeply grateful” and pledged to help make the U.S. the “Capital of Crypto.” [7]

Two weeks later, in a Nov. 3 interview with CBS News, Trump downplayed any personal connection to Zhao, telling Norah O’Donnell, “I don’t know who he is … I heard it was a Biden witch hunt.” When pressed about the optics — given that Binance helped facilitate a $2 billion purchase of the Trump family venture’s USD1 stablecoin earlier this year — Trump replied he was “too busy” and that his sons “are into” crypto. [8]

Axios’ read‑out of the interview underscored the contradiction between the president’s claim of unfamiliarity and his own family’s business ties to crypto, noting Biden‑era prosecutors had portrayed Binance’s AML lapses as a national‑security risk. The White House told Axios, “Neither the President nor his family have ever engaged, or will ever engage, in conflicts of interest.” [9]

Why the conflict‑of‑interest questions aren’t going away

Reuters’ straight‑news account of the pardon situates it squarely within a broader pro‑crypto agenda that has coincided with the Trump family’s robust digital‑asset ventures. It also reports Binance’s support for the Trump family’s World Liberty Financial (WLF) this year — including USD1 stablecoin usage in a $2 billion investment in Binance by Abu Dhabi‑backed MGX — while relaying the White House’s denial of any conflict. [10]

Legal and ethics scrutiny is accelerating on Capitol Hill. Sen. Elizabeth Warren and colleagues argued the pardon “publicly and flagrantly undermines” years of AML work and sends a message that “the law doesn’t matter.” A related Senate Banking statement seeks answers from DOJ and Treasury. [11]

The Guardian and Axios both highlighted the political blowback to the president’s “I don’t know him” defense, which has become a flashpoint in the post‑pardon narrative. [12]

Markets: what moved and why

Immediate reaction. CoinDesk data show BNB jumped on Oct. 24 with trading volume roughly 35% above its seven‑day average as traders bet the pardon could clear a path for Binance’s U.S. ambitions. One industry executive quoted by CoinDesk called the moment an “inflection point” for BNB if U.S. access improves. [13]

Today’s snapshot (11:09 UTC).

  • BTC: $101,650 (−2.1% intraday)
  • ETH: $3,287.7 (−5.8%)
  • BNB: $940.41 (−1.5%)
  • COIN: $307.32 (−7.0%)
  • MSTR: $246.99 (−6.7%)
  • DJT: $13.82 (−4.9%)

U.S. footprint watch. Post‑pardon reporting indicates Binance is exploring options to re‑enter the U.S. market, which would be a significant competitive swing factor for crypto spot volumes — and for Coinbase’s share. [14]

What the law actually allows (and doesn’t)

The Constitution gives a president broad clemency authority for federal offenses, with two bedrock limits: no power over impeachment and no reach into state crimes. The DOJ’s Office of the Pardon Attorney runs an advisory process, but presidents may bypass it. And as the Supreme Court noted in Burdick v. United States (1915), accepting a pardon can carry an implication of guilt — a nuance that shapes political debate even when the legal effect is absolute. [15]

Importantly, Zhao’s personal pardon doesn’t erase corporate obligations: reporting notes it doesn’t extend to Binance the company, which admitted to compliance failures and paid a $4.3 billion penalty. [16]

How we got here: the money trail that fuels the optics

Axios recapped how WLF’s USD1 stablecoin became part of a $2 billion transaction connected to Binance this spring — a detail also surfaced in Reuters’ background coverage. That linkage, alongside Trump’s on‑air claim of unfamiliarity with Zhao, is the foundation of today’s conflict‑of‑interest scrutiny, even as the White House rejects the premise. [17]

Expert voices

  • Karoline Leavitt, White House: Biden‑era prosecutors waged a “war on cryptocurrency,” and the president “carefully examined all pardons.” [18]
  • Changpeng “CZ” Zhao: “Deeply grateful … will do everything we can to help make America the Capital of Crypto.” [19]
  • Sen. Elizabeth Warren: The pardon “publicly and flagrantly undermines” AML enforcement and signals that “the law doesn’t matter.” [20]
  • Market perspective (CoinDesk): The move is an “inflection point” for BNB as U.S. access potentially reopens. [21]

Stock prices & near‑term forecasts (scenario analysis, not investment advice)

Crypto (BTC, ETH, BNB) — 30–45 day view

  • Base case: Macro and policy crosswinds cap rallies; Binance’s U.S. path remains uncertain pending licenses/banking. BTC $95k–$115k, ETH $3.0k–$3.6k, BNB $850–$1,050. Catalysts: Fed signals; any concrete U.S. re‑entry steps by Binance (banking partners, state approvals). Risks: renewed enforcement headlines; macro risk‑off. (Price anchors above.)
  • Upside case: Clear regulatory path or credible U.S. partnership announcements for Binance; crypto‑friendly legislation advances. BTC retests $115k–$125k; BNB pushes $1,100+. [22]
  • Downside case: Political backlash yields targeted probes; banks balk at servicing Binance; liquidity thins. BTC <$95k; BNB <$850. (Political risk drivers outlined above.) [23]

Equities (COIN, MSTR) — 30–45 day view

  • COIN: Near‑term pressure if investors price a credible Binance U.S. return cutting into U.S. spot market share; offset by trading‑volume tailwinds if crypto stays active. Range: $260–$350, skewed by headlines on Binance licensing/banking. [24]
  • MSTR: Continues to trade as a high‑beta BTC proxy; volatility tracks Bitcoin’s range. Range: $210–$300 on our BTC scenarios. (BTC anchor above.)
  • DJT: Not a pure‑play crypto stock, but headlines on Trump/crypto tend to amplify volatility; fundamentals remain idiosyncratic. High headline sensitivity.

Note: Forecasts are scenario‑based journalism, not financial advice. Digital assets are volatile; do your own diligence.

The bipartisan backdrop: how presidents use pardons

Trump’s move sits against a broader modern record. Biden used sweeping categorical pardons for federal marijuana possession in 2022 and expanded relief in 2023, while also commuting sentences for non‑violent drug offenses late in his term. Those actions — like Trump’s today — were squarely within Article II’s clemency authority but provoked partisan debate over policy aims and process. [25]

What to watch next

  1. Paper trail: The Office of the Pardon Attorney’s public ledger and any White House/DOJ releases tied to Zhao’s pardon. [26]
  2. Hill action: Follow‑up letters/hearings from Senate Banking and House oversight on conflicts and AML policy. [27]
  3. Binance in the U.S.: Concrete steps (banking partners, state MTLs, potential acquisition) that would validate re‑entry chatter and reshape market‑share math. [28]
  4. Legal fine print: Remember, pardons cover federal crimes only and don’t immunize corporate entities; regulators retain leverage over compliance, licensing, and future conduct. [29]

Sources & further reading

  • Reuters: Trump pardons convicted Binance founder ‘CZ’ Zhao; context, quotes from White House and Zhao. [30]
  • CBS News: Trump on Binance tycoon he pardoned — “I don’t know who he is.” Full segment write‑up. [31]
  • Axios: Interview recap and conflict‑of‑interest framing; White House denial of conflicts. [32]
  • CoinDesk: BNB volume/price spike analysis post‑pardon. [33]
  • Yahoo Finance: Binance exploring U.S. re‑entry after the pardon. [34]
  • Senate Banking (Minority): Sen. Warren’s statement demanding answers from DOJ/Treasury. [35]
  • Constitution/DOJ: CRS overview of pardon power; Constitution Annotated; DOJ Pardon Attorney (process). [36]
  • Fortune: Pardon applies to Zhao personally, not Binance corporate. [37]
Trump pardons convicted founder of crypto exchange Binance

References

1. www.reuters.com, 2. www.cbsnews.com, 3. www.reuters.com, 4. www.coindesk.com, 5. www.banking.senate.gov, 6. finance.yahoo.com, 7. www.reuters.com, 8. www.cbsnews.com, 9. www.axios.com, 10. www.reuters.com, 11. www.banking.senate.gov, 12. www.theguardian.com, 13. www.coindesk.com, 14. finance.yahoo.com, 15. www.congress.gov, 16. fortune.com, 17. www.axios.com, 18. www.reuters.com, 19. www.reuters.com, 20. www.banking.senate.gov, 21. www.coindesk.com, 22. finance.yahoo.com, 23. www.banking.senate.gov, 24. finance.yahoo.com, 25. bidenwhitehouse.archives.gov, 26. www.justice.gov, 27. www.banking.senate.gov, 28. finance.yahoo.com, 29. www.congress.gov, 30. www.reuters.com, 31. www.cbsnews.com, 32. www.axios.com, 33. www.coindesk.com, 34. finance.yahoo.com, 35. www.banking.senate.gov, 36. www.congress.gov, 37. fortune.com

Stock Market Today

  • DigitalOcean (DOCN) Q3 Earnings Beat Estimates, Revenue Tops Consensus
    November 5, 2025, 11:26 AM EST. DigitalOcean Holdings (DOCN) reported Q3 EPS of $0.54, beating the Zacks Consensus by $0.04 and delivering an +8% surprise after non-recurring adjustments. Year-ago EPS was $0.52. Revenue reached $229.63 million, topping the consensus by about 1.37% versus $198.48 million a year earlier. The company has surpassed EPS estimates in four straight quarters. It currently carries a Zacks Rank #3 (Hold), with investors looking to management commentary on the earnings call. Forward estimates show a current-quarter EPS of $0.46 on $234.34 million in revenue and $2.10 on $890.37 million for the full year. Year-to-date, DigitalOcean shares are up roughly 13.9%, near the S&P 500's 15.1% gain.
  • FIS Q3 Earnings Beat: EPS $1.51, Revenue $2.72B
    November 5, 2025, 11:22 AM EST. Fidelity National Information Services (FIS) reported Q3 earnings of $1.51 per share, beating the Zacks consensus estimate of $1.48. Year-ago EPS was $1.40. Excluding non-recurring items, the quarterly surprise was +2.03%. Q3 revenue rose to $2.72 billion, exceeding the consensus by 2.19% and up from $2.57 billion a year earlier. The stock has fallen about 21.8% year-to-date, underperforming the S&P 500's +15.1%. For the coming quarter, the consensus projects $1.71 in EPS on $2.73 billion in revenue; the full-year outlook is $5.76 on $10.54 billion. The shares carry a Zacks Rank #3 (Hold) as investors await management commentary and near-term revisions.
  • Viridian Therapeutics (VRDN) Q3 Loss Widens Despite Revenue Beat; Outlook Mixed
    November 5, 2025, 11:20 AM EST. Viridian Therapeutics, Inc. (VRDN) reported a Q3 loss of $1.15 per share vs the Zacks Consensus expectation of a -$1.11 loss. The result marks a year-over-year decline from -$1.09 per share. Revenue came in at $0.09 million, beating the consensus by 4.88%. Over the last four quarters, the company has topped estimates just once. The stock has gained about 18% in 2024, lagging the S&P 500's roughly 25.8% year-to-date rise. The earnings outlook remains a focal point, with the current quarterly consensus at -$1.03 on $0.09 million in revenue and the full-year consensus at -$3.94 on $0.21 million in revenue. The near-term movement will likely hinge on management commentary during the earnings call; Zacks assigns a Rank #3 (Hold).
  • Foghorn Therapeutics (FHTX) Q3 Loss Beats Revenue Estimates; Zacks Rank Holds
    November 5, 2025, 11:18 AM EST. Foghorn Therapeutics (FHTX) reported a Q3 loss of $0.25 per share, better than the Zacks Consensus of a $0.31 loss and compared with a $0.31 loss a year ago. The quarter's result is an earnings surprise of +19.35%. Revenue came in at $8.15 million, beating estimates by 1.12% versus year-ago $7.81 million. Over the last four quarters, the company has topped estimates twice. The stock has fallen about 25.2% YTD while the S&P 500 has gained ~15.1%. Ahead of the call, estimates for the next quarter sit at -$0.28 on $9.7 million in revenue, and for the full year at -$1.18 on $31.3 million. Management commentary on the earnings call will matter for near-term sentiment; Zacks currently assigns a Rank #3 (Hold).
  • X4 Pharmaceuticals (XFOR) Q3 Loss Narrower Than Expected, Revenue Miss; Zacks Rank #2 Buy
    November 5, 2025, 11:14 AM EST. X4 Pharmaceuticals (XFOR) reported a Q3 loss of $0.69 per share, narrower than the Zacks Consensus loss of $0.79 and far better than a year-ago $5.41 loss. Revenue came in at $1.77 million, missing the consensus by about 7.2%. Despite the narrower loss, the stock has fallen roughly 82% this year. Ahead of the print, Zacks flagged favorable earnings revisions and assigns a Zacks Rank #2 (Buy). The outlook for the next quarter remains hinged on management commentary and any catalysts discussed on the call, with analysts looking at next-quarter and full-year guidance and the evolving industry backdrop for Medical - Biomedical and Genetics.
NVIDIA’s $4 Trillion AI Revolution: How the Chipmaker Overtook Apple and Microsoft
Previous Story

Nvidia Just Hit $5 Trillion—But Can AMD or Intel Finally Crack Its AI Chip Moat?

Bitcoin Rebound, CBDC Ban, NFT Revival – Inside Crypto’s 48-Hour Whirlwind (Sept 23–24, 2025)
Next Story

Hong Kong Just Opened the Liquidity Floodgates: HashKey’s CaaS launch, Kraken tie‑up and a $500M IPO plan supercharge the city’s crypto reboot

Go toTop